UnitedHealth Group's Options Frenzy: What You Need to Know

Benzinga13分前

Eli Lilly's Weight Loss Med Tirzepatide Gets Endorsement From U.K.'s NICE

Seeking Alpha00:35

Ely Lilly Shares Are Trading Higher After the FDA Approved the Company's Zepbound, a Weight Loss Drug Designed to Treat Moderate-to-severe Obstructive Sleep Apnea in Adults With Obesity.

Benzinga12/24 04:45

Eli Lilly Stock Is Rising Monday: What's Going On?

Benzinga12/24 03:57

Unpacking the Latest Options Trading Trends in UnitedHealth Group

Benzinga12/24 00:45

ResMed Shares Are Trading Lower After Rival Eli Lilly Received Approval for Zepbound as an Obstructive Sleep Apnea Treatment for Obese Adults.

Benzinga12/24 00:23